本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aerovate Therapeutics, Inc.

9.80
0.0000
成交量:- -
成交额:276.85万
市值:2.84亿
市盈率:-5.76
高:9.80
开:9.80
低:9.80
收:9.80
52周最高:884.98
52周最低:9.80
股本:2,898.50万
流通股本:1,196.45万
量比:- -
换手率:- -
股息:2.40
股息率:24.49%
每股收益(TTM):-1.7025
每股收益(LYR):-2.4361
净资产收益率:-59.01%
总资产收益率:-36.18%
市净率:3.79
市盈率(LYR):-4.02

数据加载中...

2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities